Medical Marijuana, Inc. Major Investment Company AXIM® Biotechnologies Begins GMP Manufacturing Of Cannabinoid-Based Gum With Dronabinol For Use In Upcoming Clinical Studies

by Jeffrey Stamberger | Sep 12, 2019 | Axim Biotechnologies, Press Releases

SAN DIEGO, Sept. 12, 2019 — Medical Marijuana, Inc. (OTC:MJNA) (“the Company”), the first-ever publicly traded cannabis company in the United States that launched the world’s first-ever cannabis-derived nutraceutical products, brands and supply...

Medical Marijuana, Inc. Major Investment Company AXIM® Biotechnologies, Inc. Moves Forward on Oral Healthcare Line With Cannabinoid Product Supply Agreement

by Jeffrey Stamberger | Jun 13, 2019 | Axim Biotechnologies, Press Releases

SAN DIEGO, June 13, 2019 — Medical Marijuana, Inc. (OTC:MJNA) (the “Company”), the first-ever publicly traded cannabis company in the United States that launched the world’s first-ever cannabis-derived nutraceutical products, brands and supply...

Medical Marijuana, Inc. Major Investment Company Axim® Biotechnologies Files New U.S. Provisional Patent for Cannabis Gum as a Treatment for Migraine Symptoms

by Jeffrey Stamberger | May 14, 2019 | Axim Biotechnologies, Press Releases

NEW YORK, May 14, 2019 — Medical Marijuana, Inc. (MJNA), the first-ever publicly traded cannabis company in the United States, today announced that the Company’s major investment company AXIM® Biotechnologies, Inc. (AXIM) (“AXIM”), a world...

Medical Marijuana, Inc. Investment Company AXIM® Biotechnologies Enters Services Agreement with CRO to Begin Clinical Studies on Dronabinol and CBD Chewing Gums

by Jeffrey Stamberger | Apr 10, 2019 | Axim Biotechnologies, Press Releases

SAN DIEGO, April 10, 2019 — Medical Marijuana, Inc. (OTC:MJNA), the first-ever publicly traded cannabis company in the United States, announced that its investment company AXIM® Biotechnologies (“AXIM® Biotech” or “AXIM”) (OTCQB:AXIM), a...

Medical Marijuana, Inc. Portfolio Company AXIM® Biotechnologies Receives New U.S. Patent Issuance for Topical Cream Containing Cannabinoids

by Jeffrey Stamberger | Mar 27, 2019 | Axim Biotechnologies, Press Releases

SAN DIEGO, March 27, 2019 — Medical Marijuana, Inc. (OTC:MJNA), the first-ever publicly traded cannabis company in the United States, announced that its portfolio company AXIM® Biotechnologies (“AXIM® Biotech” or “AXIM”) (OTCQB:AXIM), a...

PBS NewsHour Leads Medical Marijuana, Inc. Headlines This Week

by Jeffrey Stamberger | Jan 18, 2019 | Axim Biotechnologies, Cannabis Beauty Defined, Kannalife Sciences, Media Coverage

Hemp farmers affected by government shutdown, a look at global cannabis legalization, and CBD for skin care among recent Medical Marijuana, Inc. news. The future of hemp cultivation in America, shifting cannabis policy in Mexico, and CBD beauty products are trending...